Navigation Links
Informed Medical Communications Appoints New Senior Manager, Strategic Operations
Date:3/3/2009

EDISON, N.J., March 3 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced the appointment of Kerry Crawford to the position of Senior Manager, Strategic Operations. In this critical role, Kerry will lead operations and focus on the further enhancement of IMC's client relationship management systems. This key addition is consistent with IMC's focus on meeting clients' needs for efficiency, enhanced ROI, and flexibility.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/NYM105LOGO )

Kerry brings strong operations credentials to IMC, having recently worked at Johnson & Johnson as a Manager, Sales Operations. She brings strong communications skills and vast experience negotiating with suppliers. Prior to J&J, she worked at Pfizer as a manager of convention strategy and as a sales representative. Additionally, Kerry's experience working at a medical communications company has ensured an expansive knowledge of bio-pharmaceutical client needs the service industry and supplier-side operations as well.

"Kerry's expertise and track record of success will be an asset to IMC as we continue to look for ways to maximize ROI for our clients," said Kathleen Bresette, President, The Peer Group (an IMC enterprise). "Her proven ability to find operational efficiencies while maintaining the highest level of client service will enable us to proactively support the changing needs of our clients in these challenging economic times."

About Informed Medical Communications

Informed Medical Communications (www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Dialogue Training, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.


'/>"/>
SOURCE Informed Medical Communications
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
2. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
3. Informed Medical Communications Hires New Vice President of Marketing
4. Informed Medical Communications Appoints New Chief Financial Officer
5. Informed Medical Communications Adopts Newly Enhanced Compliance Policy
6. Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedixs Med-eXpert(TM) System
7. Informed Medical Communications Highlights Opportunity in Revised PhRMA Code
8. Informed Medical Communications Appoints New Vice President, Information Technology
9. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
10. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
11. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):